SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000014272-21-000058
Filing Date
2021-02-04
Accepted
2021-02-04 08:04:33
Documents
17
Period of Report
2021-02-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmy-20210204.htm   iXBRL 8-K 48161
2 PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY DATED FEBRUARY 4, 2021 q42020ex991.htm EX-99.1 542231
3 CERTAIN SUPPLEMENTAL INFORMATION q42020ex992.htm EX-99.2 2285353
9 bmslogo20201.jpg GRAPHIC 22929
  Complete submission text file 0000014272-21-000058.txt   3219120

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmy-20210204.xsd EX-101.SCH 4011
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmy-20210204_cal.xml EX-101.CAL 852
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmy-20210204_def.xml EX-101.DEF 8970
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmy-20210204_lab.xml EX-101.LAB 35280
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmy-20210204_pre.xml EX-101.PRE 18203
10 EXTRACTED XBRL INSTANCE DOCUMENT bmy-20210204_htm.xml XML 17510
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 21588901
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences